| Antagonist activity at human recombinant FPR1 in expressed in HEK293 cells assessed as inhibition of FMLP-stimulated intracellular calcium mobilisation at 30 uM after 1 hr by FLIPR assay - BioAssay Summary Optimisation of a series of pyrazole inhibitors of the human FPR1 receptor has been achieved. The use of an in vitro media loss assay was utilised to identify sub-series with more robust DMPK profiles. These were subsequently improved to generate analogues with attractive overall profiles. ..more |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||
Target Tested Compounds: Description: Title: Lead optimisation of pyrazoles as novel FPR1 antagonists. Abstract: Optimisation of a series of pyrazole inhibitors of the human FPR1 receptor has been achieved. The use of an in vitro media loss assay was utilised to identify sub-series with more robust DMPK profiles. These were subsequently improved to generate analogues with attractive overall profiles. (PMID: 22094028) Categorized Comment ChEMBL Assay Type: Functional ChEMBL Assay Data Source: Scientific Literature ChEMBL Target ID: 13010 ChEMBL target type: Target is a single protein chain Result Definitions
Data Table (Concise) Classification
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||